Efficacy, Safety and Pharmacokinetics of 3 Doses of REC 0/0559 Eye Drops (MT8) for the Treatment of Stage 2 (Moderate) and 3 (Severe) Neurotrophic Keratitis in Adult Patients
Karo Barsamian
IMVT TED
A Phase 3, Multi-center, Randomized, Quadruple-masked, Placebo-controlled Study of Batoclimab for the Treatment of Participants with Active Thyroid Eye Disease (TED)
New nanoparticles aid sepsis treatment in mice
Tens of millions of people worldwide are affected by diseases like macular degeneration or have had accidents that permanently damage the light-sensitive photoreceptors within their retinas that enable vision.
Micro-molded ‘ice cube tray’ scaffold is next step in returning sight to injured retinas
In new research published today, UW–Madison researchers reported a new nanoparticle-based treatment for sepsis that delivers anti-inflammatory molecules and antibiotics.
Treating Antimicrobial Resistant Infections: A Nano-scale Approach with Big Impacts
Antimicrobial-resistant (AMR) infections are predicted to kill 10 million people each year by 2050—up from 700,000 in 2019—and force 24 million people into extreme poverty as early as 2030. Yet, the pharmaceutical industry has divested from the antibiotic resistance crisis, investing instead in more lucrative types of drugs.
Hoon Lab Secures UW2020 Funding
The Hoon Research Laboratory, led by Mrinalini Hoon, PhD, assistant professor, has been awarded $500,000 by the UW2020: WARF Discovery Initiative Cohort for the project, “Imaging the Third Dimension at the Nanometer Resolution.” The award …